EXCLUSIVE
The TM-Flow + ETF 128 Hz devices are both non-invasive diagnostic tools used in Primary Care, Endocrinology, Cardiology, and Podiatry clinics to assess vascularization, vascular function, and autonomic nervous system performance. They provide healthcare providers with insights into a patient’s risk for cardiovascular disease, peripheral arterial disease (PAD), and autonomic dysfunctions, including sudomotor dysfunction and loss of sensation—often associated with conditions such as diabetes, hypertension, and metabolic syndrome.
The TM-Flow + ETF 128 Hz devices are effective tools for early detection, risk stratification, and monitoring of chronic diseases, making it a valuable addition in any clinical setting.
Galvanic Skin Response Test & Bioimpedance Analysis
Bleeding-edge Photoplethysmography
Ankle Brachial Index & Volume Plethysmography
Vibroception of Sensory Nerves to Stimuli
The TM-Flow with the Electronic Tuning Fork (ETF 128 Hz)
The TM-Flow is a state-of-the-art diagnostic system designed to revolutionize patient care by providing a comprehensive and integrated approach to health assessments. Composed of five (5) assessments, the platform offers a seamless blend of cutting-edge technology and clinical precision, enabling healthcare providers to assess and monitor critical health parameters efficiently and effectively.
All of the assessments work together to deliver a holistic view of a patient’s health, focusing on vascular function, autonomic nervous system performance, and other vital metrics, ensuring that no aspect of patient care is overlooked. This innovative system empowers clinicians to detect early signs of chronic conditions, track disease progression, and implement preventive strategies tailored to each patient, ultimately enhancing outcomes and supporting value-based care initiatives.
TBL-ABI:
Measures Ankle Brachial Indices and volume plethysmography, essential for the early detection of Peripheral Artery Disease (PAD).
SweatC:
Assesses sudomotor function by measuring the Galvanic Skin Response, aiding in the evaluation of autonomic nervous system function.
LD-OXI:
Employs mathematical photoplethysmography analysis for two critical assessments:
Autonomic Nervous System Evaluation: Heart Rate Variability (HRV) analysis at rest and during Ewing Tests.
Endothelial Function Assessment: Through advanced Photoplethysmography (PTG) analysis.
ETF 128 Hz:
Measures large fiber nerves to stimuli at 128Hz
Wireless
Non-invasive
1-minute test
Portable (fits in pocket)
No disposables needed
Delivers quantitative documentation for EMRs
Five (5) vibration amplitude modes available: Descending, Ascending, Constant, Fx Test and Vibroception Average
Note: Results are independent of the TM-Flow platform and its results.
Note: The 128 Hz frequency is the recognized standard in the U.S. for testing peripheral neuropathy, particularly for evaluating vibration perception in large fiber nerve function. Widely endorsed by organizations such as the American Diabetes Association (ADA), CDC, and CMS guidelines.
ETF 128 Hz Measurement
Patient Report
